Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biohaven Ltd
(NY:
BHVN
)
41.29
+0.29 (+0.71%)
Official Closing Price
Updated: 4:10 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biohaven Ltd
< Previous
1
2
3
4
5
6
7
8
Next >
Top-Notch Biohaven Pharmaceutical Stock Trips As ALS Drug Flops In Key Test
September 29, 2022
Patients didn't show any improvements in a study meant to test multiple drugs.
Via
Investor's Business Daily
Shares of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Rise Above Previous 52-Week High
September 27, 2022
Via
Investor Brand Network
Shares of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Exceed 52-Week High
September 26, 2022
Via
Investor Brand Network
Stocks That Hit 52-Week Highs On Friday
September 23, 2022
On Friday, 5 companies hit new 52-week highs.
Via
Benzinga
Watch for Continued Gains in Shares of Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
September 23, 2022
Via
Investor Brand Network
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin
September 15, 2022
The market is struggling, yet biotech stocks are acting like it's good times again. Here's why.
Via
Investor's Business Daily
Recap: Biohaven Pharma Hldgs Q2 Earnings
August 05, 2022
Biohaven Pharma Hldgs (NYSE:BHVN) reported its Q2 earnings results on Friday, August 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Biohaven's Neurological Disease Candidate Flunks In Late-Stage Study
May 23, 2022
Via
Benzinga
Is Viatris Inc. a Contrarian Dividend Option for Your Portfolio?
September 03, 2022
Does kicking against market trends make you even more excited about investing? If so, you may want to consider drugmaker Viatris Inc. (NASDAQ: VTRS), which produces products that treat diabetes,...
Via
MarketBeat
Biohaven Pharmaceutical's Return On Capital Employed Overview
August 26, 2022
Benzinga Pro data, Biohaven Pharmaceutical (NYSE:BHVN) reported Q2 sales of $215.08 million. Earnings fell to a loss of $441.88 million, resulting in a 278.01% decrease from last quarter.
Via
Benzinga
$5.6 Million Bet On This Healthcare Stock? 3 Stocks Insiders Are Buying
August 23, 2022
Although US stocks closed sharply lower on Monday, there were a few notable insider trades.
Via
Benzinga
Freedom Biosciences Gets $10.5M In Seed Financing For Psychedelics Research, This Is What We Know
August 23, 2022
Freedom Biosciences achieved a major $10.5 million in a seed financing round in which MBX Capital, PsyMed Ventures, Village Global and The Yale Startup, among others, participated.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022
August 19, 2022
Upgrades
Via
Benzinga
Why These Pfizer Analysts Like The Global Blood Therapeutics Deal
August 08, 2022
Pfizer Inc. (NYSE: PFE) shares were trading lower Monday after the drugmaker announced a $5.4-billion bid to acquire blood disorder drugmaker Global Blood Therapeutics Inc (NASDAQ: GBT).
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
Via
Benzinga
Pfizer Is Reportedly In 'Advanced Talks' To Buy Global Blood Therapeutics For $5 Billion
August 05, 2022
Shares of Pfizer's rumored takeover target have rocketed for two days running.
Via
Investor's Business Daily
The 3 Best Market Sectors for the Second Half of 2022
July 27, 2022
Compelling themes will drive a recovery in some sectors over the second half of 2022. The following are the best market sectors to buy into.
Via
InvestorPlace
Which Coronavirus Stock Could Fetch Higher Returns?
July 11, 2022
This article will compare Pfizer, Moderna, and Novavax to see which of these coronavirus stocks will yield the highest returns.
Via
InvestorPlace
Global Coalition for Adaptive Research, Biohaven, and Vigeo Announce Commencement of Biohaven’s Troriluzole and Vigeo’S VT1021 in GBM AGILE Trial
July 06, 2022
From
Global Coalition for Adaptive Research
Via
Business Wire
Is Pfizer Stock A Buy Or A Sell As Its Covid Vaccine Faces A New Lawsuit?
July 05, 2022
The FDA's advisors recently backed Pfizer's Covid shot for young children.
Via
Investor's Business Daily
Hopeful Golden Cross Forms On Biohaven Pharma Hldgs's Chart
June 23, 2022
If history is any guide, there may be good fortune ahead for shares of Biohaven Pharma Hldgs (NYSE:BHVN). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish...
Via
Benzinga
Looking Into Biohaven Pharmaceutical's Return On Capital Employed
June 10, 2022
According to data from Benzinga Pro, during Q1, Biohaven Pharmaceutical's (NYSE:BHVN) reported sales totaled $318.85 million. Despite a 41.43% increase in earnings, the company posted a loss of $116.90...
Via
Benzinga
3 Biotech Stocks to Buy Before They Boom
June 01, 2022
It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations.
Via
InvestorPlace
Pfizer's Nearly $7 Billion Acquisition Of Arena Pharma Just Paid Off In A Big Way
May 24, 2022
The company is planning to soon ask for FDA approval of etrasimod in ulcerative colitis.
Via
Investor's Business Daily
BIOHAVEN INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Biohaven Pharmaceutical Holding Company Ltd. - BHVN
May 17, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
May 16, 2022
Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from...
Via
Benzinga
Stock Market Tries To Bounce From Fresh 2022 Lows; Tesla CEO Elon Musk Puts Twitter Deal 'On Hold': Weekly Review
May 13, 2022
Elon Musk put his Twitter deal "on hold" but says he's "still committed" to it.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022
May 11, 2022
Upgrades
Via
Benzinga
103 Biggest Movers From Yesterday
May 11, 2022
Gainers
Via
Benzinga
Why Is Biohaven Pharmaceutical (BHVN) Stock Up Today?
May 10, 2022
BHVN stock is enjoying a nearly 70% jump today after Biohaven Pharmaceutical announced it has been acquired by Pfizer.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.